Kebir and colleagues reported the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells during multiple sclerosis lesions and in experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis [28]. This evidence concerns the gene IL17A and multiple sclerosis.